📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SARS-CoV-2's evolutionary capacity is mostly driven by host antiviral molecules (2023)

First Author: Lamb K

Attributed to: Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.04.07.536037

Publication URI: http://dx.doi.org/10.1101/2023.04.07.536037

Type: Preprint